Vice President, Tax

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

- Lead RevMed's global tax function, owning strategy, operating model, governance, and execution across planning, financial reporting, compliance, and audits.

- Align tax priorities with long-term corporate strategy, supporting OUS commercial readiness, international expansion, and sustainable growth while protecting financial position and reputation.

- Act as trusted advisor to senior leadership: translate complex tax matters into clear business choices and anticipate risks and opportunities.

- Build a scalable tax organization and develop leaders, partnering with Finance, Legal, and the business while staying hands-on in critical judgments and execution.

- The role reports to Vice President of Finance and will represent Tax in front of the Audit Committee and senior executives.

Responsibilities

Global Tax Strategy and Enterprise Partnership

- Set and own the global tax strategy and multiyear roadmap, aligning priorities, investment, and outcomes with corporate goals, capital needs, and growth.

- Advise senior leadership on tax implications of strategic decisions (cash taxes, financial reporting, feasibility, compliance, reputation); escalate significant exposures to senior executives and, as appropriate, the Audit Committee.

- Lead tax planning for corporate structure, financing, IP, licensing, collaborations, and transactions; partner with Legal, Treasury, Business Development, and Finance on diligence, structuring, and implementation.

- Anticipate global tax changes, assess enterprise impact, and lead coordinated responses; establish tax policies, decision rights, and escalation thresholds.

International Expansion and Transfer Pricing

- Own tax strategy and readiness for new markets with Global Finance and Legal (entity structures, registrations, operating models, transition to local support).

- Lead global transfer pricing policy, intercompany pricing, documentation, and governance, aligned with business substance, IP, supply chain, and local requirements.

- Partner with Commercial, Supply Chain, Treasury, and others on income tax, indirect tax, tariffs, withholding, and permanent establishment issues in cross-border operations.

Tax Accounting and Financial Reporting

- Own quality, accuracy, and timeliness of global quarterly and annual provisions under US GAAP, including ASC 740 judgments, deferred taxes, valuation allowances, uncertain tax positions, and disclosures.

- Oversee the Integration of tax into the close, forecasts, long-range plans, and cash planning with Corporate Accounting, SEC Reporting, FP&A, and Treasury; explain effective tax rate drivers and material changes.

- Ultimate owner of tax accounting policies, documentation, and SOX controls; lead external auditor engagement on significant positions and resolve complex reporting matters.

Compliance, Risk Management, and Tax Audits

- Oversee global tax team that manages global compliance across US federal, state, and international obligations; define responsibilities with Payroll, Legal, local Finance, Supply Chain and service providers.

- Maximize tax attributes and incentives (R&D credits, NOLs).

-